{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:02Z","timestamp":1787026922767,"version":"build-2736575974"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01102","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T01:05:11Z","timestamp":1571706311000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Behcet's Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8"],"prefix":"10.3389","volume":"10","author":[{"given":"Hao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyou","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11926\u2013003-0066\u20139","article-title":"Behcet's syndrome: an update","volume":"5","author":"Yazici","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792\u2013200301000-00006","article-title":"The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine."},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978\u20131-62703\u2013227-8_2","article-title":"Molecular diagnosis of autoimmune blistering diseases","volume":"961","author":"Tsuruta","year":"2013","journal-title":"Methods Mol Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/ard.60.11.996","article-title":"Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51","volume":"60","author":"Direskeneli","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10067\u2013014-2589-z","article-title":"Paradoxical mucocutaneous flare in a case of Behcet's disease treated with tocilizumab","volume":"34","author":"Cantarini","year":"2015","journal-title":"Clin Rheumatol."},{"key":"B7","first-page":"171","article-title":"Interleukin-1 Inhibition in Behcet's disease","volume":"18","author":"Vitale","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/0140\u20136736(90)92643-V","article-title":"International Study Group for Behcet's Disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain."},{"key":"B11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s004150170242","article-title":"Behcet's disease: diagnostic and prognostic aspects of neurological involvement","volume":"248","author":"Siva","year":"2001","journal-title":"J Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s004150050205","article-title":"Behcet's disease and the nervous system","volume":"245","author":"Serdaroglu","year":"1998","journal-title":"J Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","article-title":"Neurological complications in Behcet's syndrome","volume":"122","author":"Kidd","year":"1999","journal-title":"Brain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/BOR.0b013e3282ff0d51","article-title":"Vasculitis in Behcet's syndrome: evidence-based review","volume":"20","author":"Reynolds","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","article-title":"Behcet's disease\u2013a contemporary review","volume":"32","author":"Mendes","year":"2009","journal-title":"J Autoimmun"},{"key":"B16","first-page":"554","article-title":"Large artery involvement in Behcet's disease","volume":"14","author":"Hamza","year":"1987","journal-title":"J Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/anr.1780320217","article-title":"Central nervous system vasculitis in Behcet's syndrome: angiographic improvement after therapy with cytotoxic agents","volume":"32","author":"Zelenski","year":"1989","journal-title":"Arth Rheum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s100169900185","article-title":"Internal carotid artery dissection in a patient with Behcet's syndrome","volume":"12","author":"Pannone","year":"1998","journal-title":"Ann Vasc Surg"},{"key":"B19","first-page":"S64","article-title":"Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behcet's disease with parenchymal involvement: presentation of four cases","volume":"29","author":"Shugaiv","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.43.1.70","article-title":"The pathergy test and Behcet's syndrome in Britain","volume":"43","author":"Davies","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"B21","first-page":"71","article-title":"Pathergy reaction in Behcet's disease: lack of correlation with mucocutaneous manifestations and systemic disease expression","volume":"18","author":"Krause","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"B22","first-page":"402","article-title":"Vascular involvement in Behcet's disease","volume":"19","author":"Koc","year":"1992","journal-title":"J Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3346\/jkms.2002.17.3.371","article-title":"The clinical significance of a pathergy reaction in patients with Behcet's disease","volume":"17","author":"Chang","year":"2002","journal-title":"J Korean Med Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/art.20334","article-title":"Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet's disease","volume":"50","author":"Ben Ahmed","year":"2004","journal-title":"Arth Rheum"},{"key":"B25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1346\u20138138.1994.tb01762.x","article-title":"Interleukin 8 in Behcet's disease","volume":"21","author":"Itoh","year":"1994","journal-title":"J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1136\/ard.54.7.610","article-title":"Serum levels of interleukin-8 in patients with Behcet's disease","volume":"54","author":"Ozoran","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1076\/ocii.12.1.53.28062","article-title":"The demonstration of serum interleukin 6\u20138, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behcet's disease with ocular involvement","volume":"12","author":"Bardak","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"B28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00417\u2013003-0668-y","article-title":"Plasma and whole-blood chemokine levels in patients with Behcet's disease","volume":"241","author":"Kaburaki","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10067\u2013003-0851-x","article-title":"Increased serum levels of interleukin-8 in polyarteritis nodosa and Behcet's disease","volume":"23","author":"Freire Ade","year":"2004","journal-title":"Clin Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease","volume":"11","author":"Evereklioglu","year":"2002","journal-title":"Mediators Inflamm"},{"key":"B31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1365\u20134632.2004.02184.x","article-title":"Serum interleukin-8 as a serologic marker of activity in Behcet's disease","volume":"44","author":"Gur-Toy","year":"2005","journal-title":"Int J Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000018426","article-title":"Adamantiades-Behcet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate","volume":"201","author":"Katsantonis","year":"2000","journal-title":"Dermatology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365\u20134632.2009.03905.x","article-title":"Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement","volume":"48","author":"Durmazlar","year":"2009","journal-title":"Int J Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","article-title":"New insights into the pathogenesis of Behcet's disease","volume":"11","author":"Pineton de Chambrun","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s004030000128","article-title":"Adamantiades-Behcet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells","volume":"292","author":"Zouboulis","year":"2000","journal-title":"Arch Dermatol Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1046\/j.1468\u20131331.2001.00300.x","article-title":"Cerebral vasculitis and ischaemic stroke in Behcet's disease: report of one case and review of the literature","volume":"8","author":"Krespi","year":"2001","journal-title":"Eur J Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0022\u2013510X(91)90188-D","article-title":"Cerebral angio- and neuro-Behcet's syndrome: neuroradiological and pathological study of one case","volume":"106","author":"Nishimura","year":"1991","journal-title":"J Neurol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/j.1572\u20130241.2008.01848.x","article-title":"Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review","volume":"103","author":"Gisbert","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1572\u20130241.2007.01187.x","article-title":"Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review","volume":"102","author":"Gisbert","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0016\u20135085(00)70140\u20135","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5217\/ir.2017.15.3.328","article-title":"NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases","volume":"15","author":"Sato","year":"2017","journal-title":"Intest Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10067\u2013010-1414\u20136","article-title":"Proposing an algorithm for treatment of different manifestations of neuro-Behcet's disease","volume":"29","author":"Borhani Haghighi","year":"2010","journal-title":"Clin Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00415\u2013013-7209\u20133","article-title":"Diagnosis and management of Neuro-Behcet's disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2014","journal-title":"J Neurol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am J Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MD.0b013e3182561a45","article-title":"Familial Mediterranean fever: risk factors, causes of death, and prognosis in the colchicine era","volume":"91","author":"Akar","year":"2012","journal-title":"Medicine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::aid-art448>3.0.co;2-h","article-title":"A double-blind trial of colchicine in Behcet's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arth Rheum"},{"key":"B48","first-page":"241","article-title":"[Intermittent hydarthrosis of the knee as a component in the picture of Behcet's disease","volume":"1","author":"Louyot","year":"1962","journal-title":"Ann Med Nancy"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1177\/0961203318811598","article-title":"Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort","volume":"27","author":"Gonzalez-Echavarri","year":"2018","journal-title":"Lupus"},{"key":"B50","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.semarthrit.2019.03.003","article-title":"Characteristics of Behcet's Disease in the American Southwest","volume":"49","author":"Muruganandam","year":"2019","journal-title":"Semin Arthritis Rheum"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01102\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T01:05:14Z","timestamp":1571706314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01102\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":50,"alternative-id":["10.3389\/fneur.2019.01102"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01102","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"article-number":"1102"}}